AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16368038
Drug: Once-monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-monthly ibandronate 150 mg
Trial: 18042311
Drug: Weekly alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly alendronate 70 mg
Trial: 14708420
Drug: Oxybutinin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutinin (0.4 mg/kg)
Trial: 9310809
Drug: Non-clonidine treatment
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-clonidine treatment
Trial: 3881558
Drug: Clonidine treatment
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine treatment
Trial: 3753293
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium antagonist (nifedipine)
Trial: 3753293
Drug: Intravenous naftidrofuryl
RxNorm normalized name: naftidrofuryl
DrugBank: Naftidrofuryl (DB13588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous naftidrofuryl with vitamin A, vitamin E, and zinc
Trial: 26588809
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g transdermal testosterone gel (TT) (N = 16)
Trial: 26588809
Drug: Anastrozole (AI)
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole (AI) 1 mg (N = 14)
Trial: 19851858
Drug: Dose-intensive neoadjuvant
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose-intensive neoadjuvant therapy
Trial: 17941031
Drug: Low-dose computed
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose computed tomography (CT) screening for lung cancer
Trial: 16188549
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy using BMPs
Trial: 11861035
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17 beta-estradiol continuously plus sequential progestagen over 1 year
Trial: 11861035
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of HRT after 12 months
Trial: 2699100
Drug: F XIII
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F XIII concentrate treatment
Trial: 24081439
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose fish oil (5.5 g/day)
Trial: 24081439
Drug: Control (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (low dose fish oil 0.4 g/day)
Trial: 23566639
Drug: 2L PEG‐3350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2L PEG‐3350 and bisacodyl tablets
Trial: 15482502
Drug: Social communication
RxNorm normalized name: cocklebur pollen extract
DrugBank: Xanthium strumarium pollen (DB10356)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social communication intervention with regular monthly therapist contact for 6 months and 2-monthly consolidation sessions for an additional 6 months.
Trial: 9274584
Drug: Ivermectin plus
RxNorm normalized name: clorsulon / ivermectin Injectable Solution [Ivermax Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin plus Albendazole (200-400 micrograms/kg ivermectin and 400 mg albendazole)
Trial: 10717746
Drug: Albendazole alone
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole alone (400 mg)
Trial: 24277961
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam 0.3 mg/kg
Trial: 27373358
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (placebo) 2 ml
Trial: 25122671
Drug: Masitinib (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Masitinib (12 mg/kg/day)
Trial: 25122671
Drug: Sunitinib (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (50 mg/day 4-weeks-on/2-weeks-off)
Trial: 20863554
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m² + Doxorubicin 45 mg/m² + G‐CSF 5 μg/kg (CD)
Trial: 20863554
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m² + Doxorubicin 45 mg/m² + G‐CSF 5 μg/kg + Paclitaxel 160 mg/m² (CDP)
Trial: 18508824
Drug: Cell phone-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell phone-based exercise programme (daily endurance walking at 80% of maximal capacity, adjusted monthly based on ISWT results)
Trial: 18508824
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (verbal instructions for daily walking exercise at home)
Trial: 17265571
Drug: etoricoxib (≥
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib (≥ 60 mg/day)
Trial: 17265571
Drug: non-naproxen traditional
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: non-naproxen traditional NSAIDs (ibuprofen and diclofenac)
Trial: 17265571
Drug: naproxen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen (1000 mg/day)
Trial: 9063785
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg acetaminophen with codeine phosphate and diphenhydramine
Trial: 23265352
Drug: L-DOPS co-administered
RxNorm normalized name: L-DOPS
DrugBank: Droxidopa (DB06262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-DOPS co-administered with entacapone
Trial: 23265352
Drug: L-DOPS alone
RxNorm normalized name: L-DOPS
DrugBank: Droxidopa (DB06262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-DOPS alone
Trial: 21303529
Drug: Preventive spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive spinal manipulative therapy (SMT) - 1 monthly session for 10 months
Trial: 21303529
Drug: Preventive spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive spinal manipulative therapy with home exercise program (SMT + exercise) - 1 monthly SMT session combined with home exercises for 10 months
Trial: 9874808
Drug: Ibuprofen (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (800 mg)
Trial: 19673707
Drug: Acetaminophen/Hydrocodone (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen/Hydrocodone (650 mg acetaminophen with 10 mg hydrocodone)
Trial: 19673707
Drug: Placebo (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (800 mg of lactose)
Trial: 15126801
Drug: Bicalutamide 150
RxNorm normalized name: bicalutamide 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 150 mg once daily
Trial: 11482747
Drug: Tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 2 mg twice daily for up to 12 months
Trial: 9444018
Drug: Praziquantel 5
RxNorm normalized name: praziquantel 57 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 5 mg/kg
Trial: 9444018
Drug: Praziquantel 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 2.5 mg/kg
Trial: 9444018
Drug: Mebendazole 800
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mebendazole 800 mg in 10d table salt
Trial: 9444018
Drug: Mebendazole 400
RxNorm normalized name: Mebendazole
DrugBank: Mebendazole (DB00643)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mebendazole 400 mg in 10d table salt
Trial: 29199013
Drug: Netarsudil 0.02%
RxNorm normalized name: NETARSUDIL 0.02% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netarsudil 0.02% once daily (q.d.)
Trial: 29199013
Drug: Netarsudil 0.02%
RxNorm normalized name: NETARSUDIL 0.02% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netarsudil 0.02% twice daily (b.i.d.)
Trial: 30653957
Drug: Timolol 0.5%
RxNorm normalized name: Timolol 0.5% Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol 0.5% twice a day (b.i.d.)
Trial: 24342252
Drug: Alternate dosing
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate dosing schedule (0, 2, 12 months)
Trial: 24342252
Drug: Standard dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosing schedule (0, 2, 6 months)
Trial: 18315966
Drug: Percutaneous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous treatment of displaced intra-articular calcaneal fractures
Trial: 14634366
Drug: Portable device
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Portable device providing extrinsic auditory feedback in gait therapy
Trial: 14634366
Drug: Conventional gait
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional gait therapy only
Trial: 1746296
Drug: Diet and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet and exercise followed by gemfibrozil therapy
Trial: 6280794
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose cyclophosphamide alone
Trial: 6280794
Drug: Cyclophosphamide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide plus high‐dose methotrexate plus vincristine
Trial: 29177407
Drug: Extra early
RxNorm normalized name: Panadol Extra
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra early standard dose of measles vaccine (MV) (Edmonston‐Zagreb strain)
Trial: 23644703
Drug: Placebo (5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5% aqueous dextrose solution)
Trial: 17377800
Drug: Morphine intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine intravenous patient‐controlled analgesia (IV PCA)
Trial: 15705921
Drug: LT4 monotherapy
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: LT4 monotherapy (n = 48)
Trial: 12730320
Drug: Model predicting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Model predicting mortality based on two or more activities of daily living (ADLs) difficulty
Trial: 1940094
Drug: Imipramine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (25 mg/daily)
Trial: 6108592
Drug: Nabilone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (4 or 5 mg)
Trial: 6108592
Drug: Nabilone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (1 or 2 mg)
Trial: 6117576
Drug: Nabilone (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (lower doses)
Trial: 31138184
Drug: Norethindrone 5
RxNorm normalized name: norethindrone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethindrone 5 mg three times daily
Trial: 31138184
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptives (OCP)
Trial: 27743908
Drug: Parent-based cognitive
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-based cognitive behavioral therapy
Trial: 19349122
Drug: Hybrid cognitive-behavioral
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid cognitive-behavioral therapy (H-CBT)
Trial: 15534251
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (5 g per day)
Trial: 15649161
Drug: Laser acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser acupuncture on P6 point and saline infusion
Trial: 15649161
Drug: Metoclopramide 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 0.1 mg.kg(‐1) i.v. and sham laser
Trial: 15649161
Drug: Sham laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham laser and saline infusion
Trial: 10578981
Drug: Sialosyl-Tn (STn)
RxNorm normalized name: sialyl Lewis A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sialosyl-Tn (STn) monoclonal antibody staining
Trial: 9081852
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg ramipril daily
Trial: 1847026
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (15,000 UaXa, subcutaneous, daily for 6 months)
Trial: 1847026
Drug: Placebo (subcutaneous,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous, daily for 6 months)
Trial: 6340974
Drug: Trimethoprim (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (250 mg)/sulfamethopyrazine (200 mg) combination given once daily after a double loading dose on the first day.
Trial: 6340974
Drug: Ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 500 mg 4-times daily.
Trial: 31655882
Drug: Glove-finger pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glove-finger pack soaked with saline solution
Trial: 27377131
Drug: Traditional occupational
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional occupational therapy intervention sessions targeting VMI skills
Trial: 22811376
Drug: MVit (VitC:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVit (VitC: 200 mg; VitE: 400 IU; VitB6: 25 mg; Folic Acid: 400 ug; VitB12: 400 ug)
Trial: 22811376
Drug: MVit +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVit + N3 (2 g N3, 760 mg EPA, 440 mg DHA)
Trial: 22811376
Drug: N3 (2
RxNorm normalized name: Naltrexone
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N3 (2 g N3, 760 mg EPA, 440 mg DHA)
Trial: 19056661
Drug: Anti-H. pylori
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-H. pylori treatment with amoxicillin (1 g twice daily) and omeprazole (20 mg twice daily)
Trial: 17908276
Drug: Concentration-controlled MMF
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentration-controlled MMF dosing
Trial: 17908276
Drug: Fixed-dose MMF
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose MMF
Trial: 11751658
Drug: Metoprolol CR/XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR/XL 12.5 mg once daily
Trial: 11751658
Drug: Metoprolol CR/XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR/XL titrated to 200 mg once daily
Trial: 10739391
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) at 5 ppm
Trial: 8116033
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous immunoglobulin (IVIG; 0.5 g/kg) for 6 doses and oral acyclovir for 3 months
Trial: 8116033
Drug: Intravenous ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ganciclovir (2.5 mg/kg) twice daily for 2 weeks followed by oral acyclovir for 3 months
Trial: 8116033
Drug: Cytogam (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytogam (100-150 mg/kg) plus 2 weeks of i.v. ganciclovir followed by 3 months of oral acyclovir
Trial: 8116033
Drug: Standard IVIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard IVIG (5 doses over 2 months)
Trial: 30286025
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy for patients with locally advanced disease
Trial: 30286025
Drug: Nonoperative management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative management in the context of the Organ Preservation in Rectal Adenocarcinoma trial
Trial: 21979399
Drug: Diabetic colon
RxNorm normalized name: Sus scrofa colon preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetic colon preparation (10 ounces of magnesium citrate 2 days prior, followed by 10 ounces of magnesium citrate and 4-L polyethylene glycol the day prior)
Trial: 21979399
Drug: Standard colon
RxNorm normalized name: COLON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard colon preparation (10 ounces of magnesium citrate and 4-L polyethylene glycol the day prior)
Trial: 27813503
Drug: Naproxen sodium,
RxNorm normalized name: Naproxen Sodium, sodium compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen sodium, paracetamol and pamabrom
Trial: 27813503
Drug: Paracetamol, pyrilamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol, pyrilamine and pamabrom
Trial: 23633128
Drug: D-mannose powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-mannose powder (2 g in 200 ml of water daily for 6 months)
Trial: 23633128
Drug: Nitrofurantoin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin (50 mg daily)
Trial: 18619113
Drug: Alcohol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.5 g/kg dose)
Trial: 15984978
Drug: VSL#3, 3,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VSL#3, 3,600 billion bacteria daily in two divided doses for 6 weeks
Trial: 8821078
Drug: L-Dopa medication
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-Dopa medication
Trial: 8821078
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of L-Dopa
Trial: 31454432
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with interval debulking
Trial: 24490769
Drug: First generation
RxNorm normalized name: First generation cephalosporin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First generation drug-eluting stents
Trial: 24490769
Drug: Latest generation
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latest generation drug-eluting stents
Trial: 20451404
Drug: Azacitidine (AZA)
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine (AZA) 75 mg/m² subcutaneously for 7 days every 28 days (n=38)
Trial: 9040303
Drug: Famciclovir 250
RxNorm normalized name: famciclovir 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 250 mg twice daily
Trial: 10193975
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (patients with a positive history of oral herpes labialis)
Trial: 2271467
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (subclavian perivascular injection after withdrawing from the artery)
Trial: 2271467
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (subclavian perivascular injection after advancing through the artery)
Trial: 7270401
Drug: Intravenous prenalterol
RxNorm normalized name: prenalterol
DrugBank: Prenalterol (DB13777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous prenalterol (PNL) 75 to 225 microgram/kg
Trial: 7270401
Drug: Intravenous prenalterol
RxNorm normalized name: prenalterol
DrugBank: Prenalterol (DB13777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous prenalterol (PNL) during exercise
Trial: 7270401
Drug: Oral prenalterol
RxNorm normalized name: prenalterol
DrugBank: Prenalterol (DB13777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prenalterol (PNL) 30 to 200 mg/day
Trial: 7270401
Drug: Oral prenalterol
RxNorm normalized name: prenalterol
DrugBank: Prenalterol (DB13777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prenalterol (PNL) vs placebo
Trial: 24231843
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of epirubicin and interferon-α2b
Trial: 17154642
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (1 mg/day)
Trial: 12897376
Drug: Fasting insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting insulin measurement
Trial: 9183341
Drug: Post-glucose insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-glucose insulin measurement
Trial: 29778331
Drug: Goal-directed perfusion
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed perfusion (GDP) strategy during cardiopulmonary bypass (CPB) aimed to maintain oxygen delivery (DO2) at ≥280 mL·min‐1·m‐2
Trial: 27260150
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg on day 1, 75 mg on days 2 and 3)
Trial: 25471907
Drug: Topical intra-articular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical intra-articular TXA (3 g of TXA in 100 mL of physiological saline solution)
Trial: 25471907
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (15 mg/kg in 100 mL of physiological saline solution, one dose before tourniquet release and another three hours after surgery)
Trial: 25471907
Drug: Topical intra-articular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical intra-articular TXA